Cell Genesys Inc.

Researchers at Cell Genesys, Inc. target oncolytic adenoviruses.
Virus Weekly; 12/15/2009; 843 words; ...its receptor on tumor cells. Replacement of the...on many types of tumor cells." "In the current...Ganesh and colleagues, Cell Genesys, Inc (see also Oncolytic...contact S. Ganesh, Cell Genesys, 500 Forbes Blvd...

FORM 8-K: NEKTAR THERAPEUTICS ANNOUNCES DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS, ELECTION OF DIRECTORS
US Fed News Service, Including US State News; 12/15/2009; 1275 words; ...Winger was with The Cooper Companies, Inc., where he held positions of increasing...board of directors of Cephalon, Inc. and Vertex Pharmaceuticals Incorporated...served on the board of directors of Cell Genesys, Inc. until its merger with BioSante...

BioSante Pharmaceuticals Monetizes a Portion of U.S. Elestrin[TM] Royalties.
Business Wire; 12/8/2009; 1254 words; ...BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today...October acquisition of Cell Genesys to complete LibiGel...BioSante Pharmaceuticals, Inc. BioSante is a specialty...BioSante's merger with Cell Genesys. More detailed information...

Novartis: - A Detailed And Comprehensive Overview Of Current Financial Position, Company Strategy, Product And Pipeline Analysis.
M2 Presswire; 12/3/2009; 1396 words; ...Pharmaceuticals - Anadys Pharmaceuticals Inc - Antisoma plc - APT Pharmaceuticals...Avalon Pharmaceuticals - Bausch & Lomb Inc - Beijing Med-Pharm Corp - Broad...Corporation - Celgene Corporation - Cell Genesys Inc - Cell Therapeutics Inc - Cerimon...

BioSante Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference.(Conference news)
Women's Health Weekly; 12/3/2009; 890 words; ...BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced...completed acquisition of Cell Genesys, as well as give a LibiGel...BioSante Pharmaceuticals, Inc. BioSante is a specialty...Biotechnology Company, Cell Genesys Inc., Consumer, Contraception...